Prevention clinical trials

Explore recruiting prevention clinical trials.

Recruiting prevention studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Prevention trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Dapirolizumab Pegol Treatment in Study Participants With Systemic Lupus Erythematosus

France, Denmark, Romania, Czechia, Hungary, Germany +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized trial of multi-factorial primary prevention in high risk subjects candidate to a lung cancer early detection CT program

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Best hypnotic drug choice for rapid sequence induction in the operating room: a 3-arm randomized trial open-labelled with blinded evaluation of the primary outcome

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, randomized, double-blind, placebo-controlled, crossover phase IIa study on the safety of EdoXaban in PortosinusOidal vaScUlar disorder (EXPOSURE)

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

RIISC Evaluation of low dose colchicine in prevention of ischemic stroke in patients with stroke due to atherosclerosis. Reducing inflammation in ischemic stroke with colchicine (riisc),

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, double-blind, parallel group, multi-center study to evaluate the long-term safety of salbutamol rescue medication when administered via metered dose inhalers containing the propellant HFA-152a or reference HFA-134a.

Spain, France, Greece, Italy, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prevention trials by city

Prevention in Toronto Prevention in Vancouver Prevention in Montreal Prevention in Calgary Prevention in Edmonton Prevention in Ottawa Prevention in Winnipeg Prevention in Quebec City Prevention in Hamilton Prevention in Kitchener Prevention in London Prevention in Halifax Prevention in New York Prevention in Los Angeles Prevention in Chicago Prevention in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease